
Capricor Therapeutics (CAPR) Earnings Dates & Reports
Capricor Therapeutics (CAPR) Most Recent Earnings
Report DateMay 13, 2025
Period EndingQ1 2025
Est. EPS-$0.32
Actual EPS-$0.53
EarningsMiss
Capricor Therapeutics (CAPR) Earnings
View the latest Capricor Therapeutics (CAPR) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Capricor Therapeutics (CAPR)
Order type
Buy in
Order amount
Est. shares
0 shares
Capricor Therapeutics (CAPR) Earnings per Share (EPS) History
Signup for full accessBrowse free
Capricor Therapeutics (CAPR) Latest Earnings
The value each CAPR share was expected to gain vs. the value each share gained.
Capricor Therapeutics (CAPR) reported its most recent earnings on May 13, 2025 for Q1 2025, posting earnings per share (EPS) of -$0.53. This exceeded analysts' expectations of -$0.32 by 65.63%, marking a Miss.
For comparison, Capricor Therapeutics reported EPS of -$0.31 in the same quarter last year.
The company is expected to announce its next earnings report on 08/06/2025, with analysts projecting an EPS of $0.
Capricor Therapeutics (CAPR) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q2 2025Aug 6, 2025 | – | Next earnings call Aug. 6, 2025 | ||
Q1 2025May 13, 2025 | -$0.32 | -$0.53 | +65.63% | |
Q4 2024Mar 19, 2025 | -$0.31 | -$0.16 | -48.39% | |
Q3 2024Nov 13, 2024 | -$0.36 | -$0.38 | +5.56% | |
Q2 2024Aug 7, 2024 | -$0.36 | -$0.35 | -2.78% | |
Capricor Therapeutics (CAPR) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Capricor Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 13, 2025 | — | — | — |
Mar 19, 2025 | — | — | — |
Nov 13, 2024 | — | — | — |
Aug 7, 2024 | — | — | — |
Capricor Therapeutics (CAPR) Earnings FAQs
Capricor Therapeutics (CAPR) last reported earnings on May 13, 2025 for Q1 2025, posting an EPS of -$0.53, which Miss the estimate of -$0.32 by 65.63%.
For Q1 2025, Capricor Therapeutics (CAPR) reported an EPS of -$0.53, missing analysts' estimate of -$0.32 by 65.63%.
For Q1 2025, Capricor Therapeutics (CAPR) Miss expectations with an actual EPS of -$0.53 vs. an estimated EPS of -$0.32.
Following the last earnings report on May 13, 2025, Capricor Therapeutics (CAPR)'s stock price moved — from — to —.
The next Capricor Therapeutics (CAPR) earnings call is scheduled for Aug. 6, 2025, where executives will discuss financial results and outlook.